Prestige Biologics Co., Ltd. 334970.KQ Stock
Prestige Biologics Co., Ltd. Price Chart
Prestige Biologics Co., Ltd. 334970.KQ Financial and Trading Overview
| Prestige Biologics Co., Ltd. stock price | 4200 KRW |
| Previous Close | 5220 KRW |
| Open | 5220 KRW |
| Bid | 5130 KRW x N/A |
| Ask | 5160 KRW x N/A |
| Day's Range | 5040 - 5340 KRW |
| 52 Week Range | 2790 - 6480 KRW |
| Volume | 265.73K KRW |
| Avg. Volume | 1.29M KRW |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
334970.KQ Valuation Measures
| Enterprise Value | 270.36B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 95.41 |
| Enterprise Value/EBITDA | -9.551 |
Trading Information
Prestige Biologics Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 21.82% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6480 KRW |
| 52 Week Low | 2790 KRW |
| 50-Day Moving Average | 4699.6 KRW |
| 200-Day Moving Average | 3934.93 KRW |
334970.KQ Share Statistics
| Avg. Volume (3 month) | 1.29M KRW |
| Avg. Daily Volume (10-Days) | 602.19K KRW |
| Shares Outstanding | N/A |
| Float | 20.26M |
| Short Ratio | N/A |
| % Held by Insiders | 56.33% |
| % Held by Institutions | 0.025% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1246.98% |
| Gross Margin | 82.68% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -10.65% |
| Return on Equity (ttm) | -53.63% |
Income Statement
| Revenue (ttm) | 2.83B KRW |
| Revenue Per Share (ttm) | 57.09 KRW |
| Quarterly Revenue Growth (yoy) | -94.50% |
| Gross Profit (ttm) | 2.35B KRW |
| EBITDA | -28308330496 KRW |
| Net Income Avi to Common (ttm) | -62585991168 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.85B KRW |
| Total Cash Per Share (mrq) | 582.73 KRW |
| Total Debt (mrq) | 129.14B KRW |
| Total Debt/Equity (mrq) | 108.26 KRW |
| Current Ratio (mrq) | 1.942 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41212657664 KRW |
| Levered Free Cash Flow (ttm) | -128014630912 KRW |
Profile of Prestige Biologics Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Cheongju-Si |
| Address | 197, Osongsaengmyeong 1-ro |
| ZIP | 28161 |
| Phone | 82 4 3232 1552 |
| Website | https://pbpharma.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars. Its product candidates include Herceptin for breast and stomach cancer; Avastin for colon, lung, and ovarian cancers; Humira for arthritis; PBP1510 for pancreatic cancer; Denosumab for bone loss, osteoporosis; Aflibercept for macular edema and metastatic colorectal cancer; Eculizumab for atypical haemolytic uremic syndrome; Ipilimumab for metastatic melanoma; and PBP1710 for solid tumors. Prestige Biologics Co., Ltd. was formerly known as PrestigeBio Pharmaceuticals and changed its name to Prestige Biologics Co., Ltd. in October 2019. The company was founded in 2015 and is based in Cheongju-si, South Korea.
Q&A For Prestige Biologics Co., Ltd. Stock
What is a current 334970.KQ stock price?
Prestige Biologics Co., Ltd. 334970.KQ stock price today per share is 4200 KRW.
How to purchase Prestige Biologics Co., Ltd. stock?
You can buy 334970.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prestige Biologics Co., Ltd.?
The stock symbol or ticker of Prestige Biologics Co., Ltd. is 334970.KQ.
How many shares does Prestige Biologics Co., Ltd. have in circulation?
The max supply of Prestige Biologics Co., Ltd. shares is 61.5M.
What is Prestige Biologics Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Prestige Biologics Co., Ltd. PE Ratio is now.
What was Prestige Biologics Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Prestige Biologics Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Prestige Biologics Co., Ltd. 334970.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Manufacturing Index KQ12 | 2760.02 KRW 2.08 USD |
-1.24
|
507.32K KRW 383 USD | 2752.51 KRW 2.08 USD | 2800.12 KRW 2.11 USD | — - | 507.32K KRW 383 USD |
| Kosdaq MID300 Index KQ300 | 770.95 KRW 0.58 USD |
-0.99
|
161.39K KRW 122 USD | 766.94 KRW 0.58 USD | 780.36 KRW 0.59 USD | — - | 161.39K KRW 122 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 8719.89 KRW 6.58 USD |
-1.16
|
44.53K KRW 34 USD | 8719.89 KRW 6.58 USD | 8888.06 KRW 6.71 USD | — - | 44.53K KRW 34 USD |
- {{ link.label }} {{link}}